ArticleScientific reports2024

Plasma-derived exosomal miR-326, a prognostic biomarker and novel candidate for treatment of drug resistant pediatric acute lymphoblastic leukemia.

Neda Saffari et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.